Toll-like receptor 4 gene polymorphism modulates phenotypic expression in patients with hereditary hemochromatosis

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 7, 2010, Pages 835-841

  Krayenbuehl, Pierre Alexandre ^a   Hersberger, Martin ^b   Truninger, Kaspar ^d   Müllhaupt, Beat ^a   Maly, Friedrich E ^f   Bargetzi, Mario ^e   Schulthess, Georg ^c  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b Division of Visceral and Transplant Surgery   (United Kingdom)

^c Medical Clinic   (United Kingdom)

^d Hospital of Langenthal SRO   (United Kingdom)

^e Kantonsspital Aarau   (Switzerland)

^f INSTAND WHO Collaborating Centre for Quality Assurance and Standardization in Laboratory Medicine   (United Kingdom)

Author keywords

hereditary hemochromatosis; liver fibrosis; toll like receptor 4; tumor necrosis factor alpha

Indexed keywords

ASPARAGINE; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GLYCINE; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA; HFE PROTEIN, HUMAN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN; NOD2 PROTEIN, HUMAN; TLR9 PROTEIN, HUMAN;

ADULT; ARTHROPATHY; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; HEMOCHROMATOSIS; HEREDITARY HEMOCHROMATOSIS; HOMOZYGOSITY; HUMAN; IRON OVERLOAD; LIVER BIOPSY; LIVER DISEASE; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; METACARPOPHALANGEAL JOINT; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; WILD TYPE; COMPLICATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HETEROZYGOTE; LIVER CIRRHOSIS; MIDDLE AGED; MUTATION; NEUROPATHIC JOINT DISEASE; PATHOLOGY; PENETRANCE; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

ADULT; ARTHROPATHY, NEUROGENIC; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; LIVER CIRRHOSIS; MALE; MEMBRANE PROTEINS; METACARPOPHALANGEAL JOINT; MIDDLE AGED; MUTATION; NOD2 SIGNALING ADAPTOR PROTEIN; PENETRANCE; PHENOTYPE; POLYMORPHISM, GENETIC; RETROSPECTIVE STUDIES; TOLL-LIKE RECEPTOR 4; TOLL-LIKE RECEPTOR 9;

EID: 77953997510     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e3283322067     Document Type: Article

References (35)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 1996; 13:399-408.
2. Bacon BR, Powell LW, Adams PC, Kresina TF, Hoofnagle JH. Molecular medicine and hemochromatosis: At the crossroads. Gastroenterology 1999; 116:193-207.
3. Olynyk JK, Cullen DJ, Aquilia S, Rossi E, Summerville L, Powell LW. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999; 341:718-724.
4. Bulaj ZJ, Ajioka RS, Phillips JD, LaSalle BA, Jorde LB, Griffen LM, et al. Disease-related conditions in relatives of patients with hemochromatosis. N Engl J Med 2000; 343:1529-1535.
5. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845 G> A (C282Y) HFE hereditary hemochromatosis mutation in the USA. Lancet 2002; 359:211-218.
6. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001; 2:675-680. (Pubitemid 32747155)
7. Asehnoune K, Strassheim D, Mitra S, Kim JY, Abraham E. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B. J Immunol 2004; 172:2522-2529.
8. Abraham E. Nuclear factor-kappaB and its role in sepsis-associated organ failure. J Infect Dis 2003; 187 (Suppl 2):S364-S369.
9. Tsujimura H, Tamura T, Kong HJ, Nishiyama A, Ishii KJ, Klinman DM, et al. Toll-like receptor 9 signaling activates NF-kappaB through IFN regulatory factor-8/IFN consensus sequence binding protein in dendritic cells. J Immunol 2004; 172:6820-6827.
10. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, Belaiche J, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 2001; 411:599-603.
11. Van Heel DA, Ghosh S, Butler M, Hunt KA, Lundberg AM, Ahmad T, et al. Muramyl dipeptide and toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 2005; 365:1794-1796.
12. Van Heel DA, Ghosh S, Hunt K, Mathew C, Forbes A, Jewell D, et al. Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease. Gut 2005; 54:1553-1557.
13. Kiechl S, Lorenz E, Reindl M, Wiedermann CJ, Oberhollenzer F, Bonora E, et al. Toll-like receptor 4 polymorphisms and atherogenesis. N Engl J Med 2002; 347:185-192.
14. Franchimont D, Vermeire S, El Housni H, Pierik M, Van Steen K, Gustot T, et al. Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis. Gut 2004; 53:987-992.
15. Lorenz E, Mira JP, Frees KL, Schwartz DA. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162:1028-1032.
16. Torok HP, Glas J, Tonenchi L, Bruennler G, Folwaczny M, Folwaczny C. Crohn's disease is associated with a toll-like receptor-9 polymorphism. Gastroenterology 2004; 127:365-366.
17. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411:603-606.
18. Krayenbuehl PA, Walczyk T, Schoenberg R, von Blanckenburg F, Schulthess G. Hereditary hemochromatosis is reflected in the iron isotope composition of blood. Blood 2005; 105:3812-3816.
19. Krayenbuehl PA, Maly FE, Hersberger M, Wiesli P, Himmelmann A, Eid K, et al. Tumor necrosis factor-alpha -308G> A allelic variant modulates iron accumulation in patients with hereditary hemochromatosis. Clin Chem 2006; 52:1552-1558.
20. Bacon BR, Olynyk JK, Brunt EM, Britton RS, Wolff RK. HFE genotype in patients with hemochromatosis and other liver diseases. Ann Int Med 1999; 130:953-962.
21. Barton JC, McDonnell SM, Adams PC, Brissot P, Powell LW, Edwards CQ, et al. Management of hemochromatosis. Hemochromatosis Management Working Group. Ann Int Med 1998; 129:932-939.
22. Hersberger M, Marti-Jaun J, Rentsch K, Hänseler E. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR. Clin Chem 2000; 46 (8 pt 1): 1072-1077.
23. Rüegg C, Hersberger M, Wusk B, Rentsch K, Kullak-Ublick GA, von Eckardstein A, et al. Detection of the Arg702Trp, Gly908Arg and Leu1007fsinsC polymorphisms of the NOD2/CARD15 gene by real-time PCR with melting curve analysis. Clin Chem Lab Med 2004; 42:494-498.
24. Ameziane N, Beillat T, Verpillat P, Chollet-Martin S, Aumont MC, Seknadji P, et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler Thromb Vasc Biol 2003; 23:e61-e64.
25. Van-der-Paardt M, Crusius JB, de Koning MH, Morre SA, van-de-Stadt RJ, Dijkmans BA, et al. No evidence for involvement of the Toll-like receptor 4 (TLR4) A896G and CD14-C260T polymorphisms in susceptibility to ankylosing spondylitis. Ann Rheum Dis 2005; 64:235-238.
26. Bochud PY, Hersberger M, Taffè P, Bochud M, Stein CM, Rodrigues SD, et al. The Swiss HIV Cohort Study. Polymorphisms in Toll-like receptor 9 influence the clinical course of HIV-1 infection. AIDS 2007; 21:441-446.
27. Pietrangelo A. Hereditary hemochromatosis - a new look at an old disease. N Engl J Med 2004; 350:2383-2397.
28. Seki E, De Minicis S, Osterreicher CH, Kluwe J, Osawa Y, Brenner DA, et al. TLR4 enhances TGF-beta signaling and hepatic fibrosis. Nat Med 2007; 13:1324-1332.
29. Puthothu B, Forster J, Heinzmann A, Krueger M. TLR-4 and CD14 polymorphisms in respiratory syncytial virus associated disease. Dis Markers 2006; 22:303-308.
30. Braat H, Stokkers P, Hommes T, Cohn D, Vogels E, Pronk I, et al. Consequence of functional Nod2 and Tlr4 mutations on gene transcription in Crohn's disease patients. J Mol Med 2005; 83:601-609.
31. Gazouli M, Mantzaris G, Kotsinas A, Zacharatos P, Papalambros E, Archimandritis A, et al. Association between polymorphisms in the Toll-like receptor 4, CD14, and CARD15/NOD2 and inflammatory bowel disease in the Greek population. World J Gastroenterol 2005; 11:681-685.
32. Pabst S, Baumgarten G, Stremmel A, Lennarz M, Knüfermann P, Gillissen A, et al. Toll-like receptor (TLR) 4 polymorphisms are associated with a chronic course of sarcoidosis. Clin Exp Immunol 2006; 143:420-426.
33. Bridle KR, Crawford DH, Fletcher LM, Smith JL, Powell LW, Ramm GA. Evidence for a sub-morphological inflammatory process in the liver in haemochromatosis. J Hepatol 2003; 38:426-433.
34. Moura E, Verheul AF, Marx JJ. A functional defect in hereditary haemochromatosis monocytes and monocyte-derived macrophages. Eur J Clin Invest 1998; 28:164-173.
35. Gordeuk VR, Ballou S, Lozanski G, Brittenham GM. Decreased concentrations of tumor necrosis factor-alpha in supernatants of monocytes from homozygotes for hereditary hemochromatosis. Blood 1992; 79:1855-1860.